Financial Performance

Beyond green pledges, Cornerstone Relocation is operationalizing sustainability, turning ESG metrics into a competitive advantage in the global mobility race.

Astreya's ranking on TIME's inaugural WorkTech list is more than an award. It's a spotlight on the critical 'stage crew' companies building the practical AI foundation for the future of work.

Foundry Nation's new THC-infused colas tap into nostalgia, but their success hinges on navigating a complex web of consumer trends and looming regulations.

For millions, using stablecoins meant a frustrating extra step. A quiet change in wallet technology is making crypto feel more like digital cash.

A biotech firm's non-hallucinogenic drug just passed a key safety test. Could this novel approach finally disrupt the challenging world of alcohol use disorder?

Bitget lists AIVIVE, an AI protocol using revenue to burn tokens. The move signals a strategic push to solve AI's value problem, but can it work?

A new patent gives Cognition Therapeutics’ lead drug candidate protection until 2045. Here’s why this strategic move is about more than just IP.

A new investment in clean alumina tech is more than a deal; it’s a strategic move to build a Western-controlled critical materials corridor in the Arctic.

A new Forrester study reveals a staggering 432% ROI for Button's AI. We analyze how this tech goes beyond deep-linking to solve mobile commerce's costly friction problem.

Acumen Pharmaceuticals unveils two new candidates using a novel technology to deliver therapies directly to the brain, promising a more effective fight against AD.

Brixton Metals unveils stunning high-grade silver at its historic Langis Project, pushing aggressively toward a maiden resource and commercial viability.

Circular Services' new Florida facility isn't just about recycling; it's a blueprint for a new class of ESG infrastructure creating value and reducing risk.

Neura Defense Systems emerges from stealth with an AI-native platform, aiming to defeat the cheap, silent drones that have upended modern military math.

Global Jet Capital's latest securitization is more than a big number. It's a barometer for investor trust, a fuel injection for business aviation, and a key signal in a complex market.

QuickLogic heads to the Northland Growth Conference, ready to showcase its critical defense and AI tech. Can leadership turn niche dominance into market momentum?

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

The appointment of drug development veteran Dr. Aaron Koenig at Syremis Therapeutics is more than a new hire; it's a strategic play in the high-stakes race to redefine mental health treatment.

Manchester United partners with Elevate, using AI to redefine the Old Trafford experience. But can data-driven luxury coexist with the soul of the game?

Pasithea Therapeutics is expanding its NF1 trial for PAS-004, a move that signals a deeper strategic commitment to outmaneuvering competitors and meeting a critical unmet medical need.

German firm NVision wins a top award for POLARIS, a quantum-enhanced MRI platform that shows if cancer therapy is working weeks or months sooner.